0001203311-13-000080.txt : 20130905 0001203311-13-000080.hdr.sgml : 20130905 20130905175512 ACCESSION NUMBER: 0001203311-13-000080 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130903 FILED AS OF DATE: 20130905 DATE AS OF CHANGE: 20130905 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SEATTLE GENETICS INC /WA CENTRAL INDEX KEY: 0001060736 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911874389 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4255274000 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SIEGALL CLAY B CENTRAL INDEX KEY: 0001167496 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-32405 FILM NUMBER: 131081322 MAIL ADDRESS: STREET 1: 21823 30TH DR SE CITY: BOTHELL STATE: WA ZIP: 98021 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2013-09-03 0 0001060736 SEATTLE GENETICS INC /WA SGEN 0001167496 SIEGALL CLAY B 21823 30TH DRIVE SE BOTHELL WA 98021 1 1 0 0 President and CEO Common Stock 2013-09-03 4 M 0 2000 10.33 A 1079211 D Common Stock 2013-09-03 4 S 0 2000 42.7659 D 1077211 D Common Stock 2013-09-03 4 S 0 100000 43.9227 D 977211 D Non-Qualified Stock Option (right to buy) 10.33 2013-09-03 4 M 0 2000 0 D 2005-01-30 2014-02-17 Common Stock 2000 7858 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Dr. Siegall and described in a Form 8-K filed on June 15, 2012. $42.7659 represents an average price per share for the shares sold on 9/3/2013. The sell price for shares sold on this day ranged from $42.66 to $42.88. Amount of Securites beneficially owned following reported transactions includes 189,250 restricted Stock units subject to vesting. $43.9227 represents an average price per share for the shares sold on 9/4/2013. The sell price for shares sold on this day ranged from $43.70 to $44.265. 25% of the shares vested on 1/30/05. The remainder vested monthly thereafter until all shares were full vested on 1/30/08. Clay B. Siegall 2013-09-05